Industry News

Pharmaceutical Industry News

Pfizer is launching the first…

November 14th, 2025|Fierce Pharma|

Pfizer is launching the first clinical trials for its PD-1xVEGF drug, while Akeso detailed the first overall survival win for its first-in-class ivonescimab. Eli Lilly signed two more drug discovery pacts. And more.

An Association of Black…

November 14th, 2025|Fierce Pharma|

An Association of Black Cardiologists survey has found a widespread gap in cardiovascular health awareness, generating data to support the need for an Amgen-backed education campaign.

Luc Debruyne, who took the top…

November 13th, 2025|Fierce Pharma|

Luc Debruyne, who took the top spot on Danish vaccine specialist Bavarian Nordic’s board of directors in early 2023, has stepped down from his post, effective immediately. Debruyne’s exit from the board follows—and is directly

Both Eli Lilly and Novo Nordisk…

November 13th, 2025|Fierce Pharma|

Both Eli Lilly and Novo Nordisk are denying a telehealth company’s claim of having struck partnerships with the two companies to provide direct access to their popular obesity meds.

Weeks after launching its first…

November 13th, 2025|Fierce Pharma|

Weeks after launching its first open call for diabetes advocates, Dexcom is spotlighting the resulting group of 16 people in a new awareness campaign.

Kyowa Kirin’s big bet on Kura…

November 13th, 2025|Fierce Pharma|

Kyowa Kirin’s big bet on Kura Oncology has paid off in short order, delivering an FDA approval for a medicine to treat a subset of patients with acute myeloid leukemia.

South Korea’s Boryung…

November 13th, 2025|Fierce Pharma|

South Korea’s Boryung Corporation continues to boost its production footprint by kicking off a project that will double the capacity of its penicillin manufacturing facility in its home country.

For people who are currently on…

November 13th, 2025|Fierce Pharma|

For people who are currently on multi-tablet HIV regimens, many of whom are also on medicines for other conditions, the findings are "significant," an expert said.

Since the start of the month,…

November 12th, 2025|Fierce Pharma|

Since the start of the month, several drug recalls have entered the FDA’s periphery, affecting products ranging from hospital drugs and potassium deficiency injections to antibiotics and a generic medicine for attention-deficit/hyperactivity disorder.

The survey, commissioned by the…

November 12th, 2025|Fierce Pharma|

The survey, commissioned by the Alliance for Aging Research and sponsored by the two drugmakers, spanned 1,000 U.S. adults and 1,000 unpaid or family Alzheimer’s caregivers.

“At this point, the abstract was…

November 12th, 2025|Fierce Pharma|

“At this point, the abstract was withdrawn in alignment with the authors, and we are looking forward to future opportunities to share the data,” Legend’s president of Carvykti, Alan Bash, said Wednesday.

Despite the largely stagnant…

November 12th, 2025|Fierce Pharma|

Despite the largely stagnant performance this past quarter, Bayer remains “encouraged by the resilience of our top line” in pharmaceuticals, CEO Bill Anderson said on a conference call Wednesday. Still, the CEO admitted that the

The FDA has named the longtime…

November 11th, 2025|Fierce Pharma|

The FDA has named the longtime leader of its oncology department, Richard Pazdur, M.D., as the new director of the Center for Drug Evaluation and Research, which oversees most prescription drugs.